← Back to Search

High-Intensity Interval Training for Sarcopenia

N/A
Recruiting
Research Sponsored by Creighton University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
65-95 years of age or older
Physical independent (Barthel Index)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline to immediately after the hiit intervention
Awards & highlights

Study Summary

This trial will compare a 12-week high-intensity interval training program with a focus on cardiovascular endurance, neuromuscular function, and muscle architecture in older adults.

Who is the study for?
This trial is for older adults aged 65-95 who are physically independent and have not changed medications in the last month. They should not have done any structured resistance training recently and must get a doctor's okay to do high-intensity workouts.Check my eligibility
What is being tested?
The study tests a Total Body HIIT program over 12 weeks, focusing on improving cardiovascular endurance, muscle function, and structure in older adults through resistance circuits and anaerobic cycling exercises.See study design
What are the potential side effects?
Potential side effects may include increased risk of injury due to intense activity, muscle soreness, joint stress, fatigue, or cardiovascular strain. Specific risks will depend on individual health conditions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 65 and 95 years old.
Select...
I can take care of myself without help.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline to immediately after the hiit intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline to immediately after the hiit intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Interventional procedure
Interventional procedure
Interventional procedure
+7 more
Secondary outcome measures
Change in Balance: Berg Balance Scale from baseline to following HIIT intervention
Interventional procedure
Change in Balance: Functional Gait Assessment from baseline to following HIIT intervention
+5 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Total Body HIIT ProgramExperimental Treatment1 Intervention
This Total Body HIIT program (circuit and bike training) will involve 3 sessions per week (35-40 min on nonconsecutive days) progressed across the 12 weeks. All session will be lead by undergraduate exercise science students or doctor of physical therapy students and supervised by a physical therapist.

Find a Location

Who is running the clinical trial?

Creighton UniversityLead Sponsor
125 Previous Clinical Trials
25,636 Total Patients Enrolled
University of NebraskaOTHER
541 Previous Clinical Trials
1,144,693 Total Patients Enrolled

Media Library

Total Body HIIT Program Clinical Trial Eligibility Overview. Trial Name: NCT05542758 — N/A
Sarcopenia Research Study Groups: Total Body HIIT Program
Sarcopenia Clinical Trial 2023: Total Body HIIT Program Highlights & Side Effects. Trial Name: NCT05542758 — N/A
Total Body HIIT Program 2023 Treatment Timeline for Medical Study. Trial Name: NCT05542758 — N/A
~17 spots leftby Dec 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top